This article mentions some breast cancer vaccine and other cancer vaccine breakthroughs:
http://www.firstpost.com/living/breakthrough-in-immunotherapy-could-cure-cancer-300846.html
The newer vaccine testings tend to target earlier stages, unfortunately. The later stages of breast cancer might also benefit from a multi-pronged attack like the AIDS cocktails. A lot more work is needed.
I found its coverage of business aspect of vaccine development particularly interesting. Especially in light of some recent postings on whether Neuvax will be a hit or dud:
http://www.thestreet.com/story/11507036/1/galenas-breast-cancer-vaccine-doomed-to-fail.html?cm_ven=GOOGLEN
http://seekingalpha.com/article/525841-mark-ahn-interview-neuvax-demonstrated-preclinical-and-clinical-benefit-in-all-levels-of-her2-expression?source=feed
Well, only clinical trials would tell.
No comments:
Post a Comment